Evidence map›Paper›PMID 40671720›Full record

ArticleEuropean heart journal. Case reports2025

Pickering syndrome facilitated by seronegative immune mediated necrotizing myopathy: a case report.

Julija Bienz, Théo Arthur Meister, Rodrigo Soria, Martina Boscolo Berto, Emrush Rexhaj

Abstract readCase Reports
In one paragraph

Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Julija BienzZeughaus Praxis (Internal Medicine and Cardiology), Zeughausgasse 29, 3011 Bern, Switzerland.
Théo Arthur MeisterDepartment of Cardiology and BioMedical Research, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 20, 3010 Bern, Switzerland.
Rodrigo SoriaDepartment of Cardiology and BioMedical Research, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 20, 3010 Bern, Switzerland.ORCID https://orcid.org/0000-0002-1730-8429
Martina Boscolo BertoDepartment of Cardiology and BioMedical Research, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 20, 3010 Bern, Switzerland.
Emrush RexhajDepartment of Cardiology and BioMedical Research, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 20, 3010 Bern, Switzerland.ORCID https://orcid.org/0000-0002-0834-7637

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Immune-mediated necrotizing myopathies (IMNM) are rare types of idiopathic inflammatory myopathies characterized by severe proximal muscle weakness and muscle fibre necrosis with a paucity of inflammatory cells. Serologically, IMNM are further classified into three subtypes based on the presence or absence of two specific autoantibodies: the anti-3-hydroxy-3-methylglutaryl coenzyme A reductase and the anti-signal recognition particle. Especially the seronegative form exhibits a higher risk of various extra skeletal muscle involvement, including cardio-myositis. Nevertheless, severe cardiac involvement remains an extremely rare yet potentially life-threatening clinical manifestation of seronegative IMNM. Case summary: A 59-year-old male previously diagnosed with seronegative IMNM presented with severe hypertension and acute cardiac decompensation. On echocardiography, cardiac function was reduced with signs of eccentric left ventricular hypertrophy. Coronary angiography was normal, but cardiac magnetic resonance (CMR) found diffuse intra-myocardial oedema. The patient was suspected of having IMNM associated cardio-myositis and was started on heart failure therapy. In parallel, his immunosuppressive treatment was increased. Under this regiment, the patient rapidly developed acute renal failure caused by bilateral renal artery stenosis. After successful stenting of the stenotic arteries, cardiac and renal function significantly improved, and at 1-year follow-up, no more signs of myocardial oedema or inflammation were found on CMR. Discussion: Here, we describe a new case of acute congestive heart failure facilitated by severe reno-vascular hypertension in a patient with seronegative IMNM. This case highlights the importance of early recognition and treatment of hypertension in IMNM patients to avoid major adverse cardiac events.

Indexed as

Acute congestive heart failureAtherosclerotic reno-vascular hypertensionCase reportImmune-mediated necrotizing myopathy

Identifiers

PMID40671720
PMCPMC12265464

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.